CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence-Reference-Cited by-同舟云学术

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence

Published:2013-07-31 Issue:20 Volume:119 Page:3696-3702
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Colombo Chiara¹,Miceli Rosalba²,Lazar Alexander J.³⁴,Perrone Federica⁵,Pollock Raphael E.⁴⁶,Le Cesne Axel⁷,Hartgrink Henk H.⁸,Cleton-Jansen Anne-Marie⁹,Domont Julien⁷,Bovée Judith V. M. G.⁹,Bonvalot Sylvie¹⁰,Lev Dina⁴¹¹,Gronchi Alessandro¹

Affiliation:

1. Sarcoma Service; Department of Surgery; Scientific Institute for Research; Hospitalization; and Health Care (IRCCS) Foundation; National Cancer Institute; Milan Italy

2. Unit of Clinical Epidemiology and Trial Organization; IRCCS Foundation; National Cancer Institute; Milan Italy

3. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. The Sarcoma Research Center; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Pathology; IRCCS Foundation; National Cancer Institute; Milan Italy

6. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

7. Department of Medical Oncology; Gustave Roussy Institute; Villejuif France

8. Department of Surgery; Leiden University Medical Center; Leiden The Netherlands

9. Department of Pathology; Leiden University Medical Center; Leiden The Netherlands

10. Department of Surgery; Gustave Roussy Institute; Villejuif France

11. Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28271/fullpdf

Reference18 articles.

1. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles;Phillips;Br J Surg.,2004

2. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution;Gronchi;J Clin Oncol.,2003

3. Optimizing treatment of desmoid tumors;Lev;J Clin Oncol.,2007

4. Increased Beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors);Alman;Am J Pathol.,1997

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA in Patients with Desmoid Fibromatosis during Active Surveillance;Annals of Surgical Oncology;2024-09-07

2. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor;European Journal of Cancer;2024-09

3. Multifocal Desmoid-Type Fibromatosis: Case Series and Potential Relationship to Neuronal Spread;Cureus;2024-02-07

4. Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives;Cancer Treatment Reviews;2024-02

5. CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma;Virchows Archiv;2024-01-06